| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.98▼ | 1.98▼ | 1.97▼ | 1.86▲ | 1.89▲ |
| MA10 | 1.98▼ | 1.96▲ | 1.92▲ | 1.86▲ | 2.18▼ |
| MA20 | 1.98▼ | 1.91▲ | 1.89▲ | 1.90▲ | 2.61▼ |
| MA50 | 1.97▼ | 1.89▲ | 1.85▲ | 2.25▼ | 2.63▼ |
| MA100 | 1.92▲ | 1.85▲ | 1.82▲ | 2.77▼ | 4.22▼ |
| MA200 | 1.89▲ | 1.80▲ | 2.00▼ | 2.67▼ | 8.25▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.007▲ | 0.013▲ | 0.036▲ | -0.104▼ |
| RSI | 45.149▼ | 64.220▲ | 62.027▲ | 48.807▼ | 42.934▼ |
| STOCH | 66.667 | 84.471▲ | 91.610▲ | 56.142 | 16.897▼ |
| WILL %R | -66.667 | -15.152▲ | -12.195▲ | -7.692▲ | -73.354 |
| CCI | -82.486 | 65.196 | 90.458 | 116.601▲ | -93.147 |
| MA | $ANVS Price Crossed Above MA(26) | Set Alert |
|
Thursday, April 02, 2026 12:29 AM
MALVERN, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
|
|
Tuesday, March 03, 2026 12:00 AM
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/04/26 | 1.86 | 1.995 | 1.86 | 1.97 | 1,054,529 |
| 29/04/26 | 1.90 | 1.90 | 1.79 | 1.84 | 653,023 |
| 28/04/26 | 1.89 | 2.005 | 1.85 | 1.85 | 1,330,004 |
| 27/04/26 | 1.78 | 1.935 | 1.75 | 1.89 | 1,022,138 |
| 24/04/26 | 1.73 | 1.82 | 1.73 | 1.74 | 856,181 |
| 23/04/26 | 1.82 | 1.8393 | 1.7301 | 1.81 | 1,119,084 |
| 22/04/26 | 1.89 | 1.9099 | 1.81 | 1.84 | 810,867 |
| 21/04/26 | 1.90 | 1.97 | 1.85 | 1.86 | 901,886 |
| 20/04/26 | 1.86 | 1.95 | 1.81 | 1.92 | 894,217 |
| 17/04/26 | 1.82 | 1.92 | 1.77 | 1.87 | 1,076,476 |
|
|
||||
|
|
||||
|
|